Oncology Flashcards
Cytology indication
Lesion palpable external/ seen on image
Organomegaly
Cavitary effusion
Cancer staging
Pyrexia of unknown origin
Cyto expectations
Inflammation/ neoplasia
Benign/ malignant
Can’t do-
Hyperplasia/ adenoma
Cyto adv/ dis
Advantages -
non invasive
inexpensive equipment
done in house
rapid results
Dis -
May not be definitively diagnostic
Need sample to be of diagnostic quality
Slide evaluations
Macroscopic- label and smeared correctly
Micro
-10x scan whole slide, find most representative area
- higher magnification to ID cells and morphology
Sample quality problems
Thickness
Insufficient staining time
Inadequate drying
-Nuclei don’t pop- more staining needed
-bubbles- aspiration pressure, repeat with needle only technique
-cells balled up- slow drying
Inflammation or neoplasia
Inflammation
-inflammatory cells, microbes, fibroblasts
Neoplasia
-monomorphic atypical cells
-abnormal cells for site of collection
Neoplasms can become inflamed
-SCC, mammary, mast cell
Inflammation types
Neutrophilic
-imm-mediate, pathogens
Histio/macrophage
- FB, fungus, Mycobacterium
Eosinophilic
-hypersensitivity, parasites, cancer
Lympo/lymphoplasmacytic
- antigenic stimulation, Chr inflammation
Benign tumour cyto
Uniform
Delineated
Low mitotic count
Low nuclear: cytoplasmic ratio
Malignant neoplasia cyto
Pleomorphism
Anisokaryosis: Atypical nuclear: cytoplasmic ration
High and varied mitotic count
Clumped chromatin
Multinucleation
Epithelial neoplasms
Tight clumped cells
Distinct cytoplasmic borders
Sebaceous adenoma
Raised cauliflower alopecic lesions
Foamy cytoplasm
Perianal gland tumour
Entire males
Sheets of hepatocyte like cells
Large oval cells
Squamous cell carcinoma
Proliferative and ulcerative lesions
Limbs, pinnae, faces
Polygonal cells, pleomorphic
Highly malignant and invasive
Mammary carcinoma
Background blood, basophilic
Variable cellular arrangement
Pleomorphic
Mesenchymal tumours
Poor delineation
Soft tissue sarcoma
-fibro, lipo, leiomyo, rhabdmyo, perivascular
=
Lipoma
Benign
Can’t distinguish from normal subcut adipose tissue on cytology
Osteosarcoma
Round/ spindle cells
Basophilic cytoplasm
Eccentrically placed nucleus and prominent nucleoli
Osteoclasts - large multinucleated cells may be present
Round cell tumours
Cells exfoliate individually
Round cells with distinct borders
Ex
- transmissible veneral, mast cell, lymphoma, plasmacytoma
Histiocytoma
Dome shaped, alopecia
Younger dogs, regresses after few weeks
Small lymphocytes common
Plasmacytoma
Cutaneous plasmacytoma is benign
Deep blue cytoplasm
Round eccentric nuclei
Lymphoma
Round
High nuclear: cytoplasm ration
Large lymphocytes
Monomorphic population
Mast cell tumour
Breed related - boxer/ pug
Vary in granularity
less granular -> more aggressive
Eosinophils often seen aswell
(Neuro) endocrine tumour
Exfoliate into loose sheets
Naked nuclei in lakes of cytoplasm
Highly cellular samples
Ex-
-thyroid, phaeochromocytoma
Thyroid carcinoma
Blood in background
Clusters cells with scattered naked nuclei
Extracellular pink colloid often seen
Phaeochromocytoma
Chromaffin cells in adrenal medulla
CS from catecholamine release
Naked nuclei in basophilic cytoplasm lake
Melanoma
Raised dark hairless mass
Malignant - variable pigmentation, inflammed
Pleomorphic
Forms of radiotherapy
Various protocols for visits (weekly/ daily)
Brachytheraypy
-Direct aplication
-implantation
-Systemic administration
Teletherapy
-External beam
High energy electromagnetic radiation
Analgesic and carcinogenic
Compton theory
-high frequency photons scattering following an interaction with a charged particle
Damage is caused by H2O ionisation (around DNA)
-free radicals produced harm DNA
Rapid repaired unless O2 fixation
Cell death
-apoptosis, cell cycle arrest, mitotic catastrophe
Radio beam
Shaped with jaw
Margins
Multiple beams increase tumour dose whilst sparing surrounding tissue
E-: direct ionisation, loses energy rapidly through tissue (superficial tumours)
RT response
Repair of sublethal cell damage
-repair capacity for tumour and self similar
Repopulation
-rapidly dividing tissue
Redistribution
ReO2
-may occur after therapy
Fractionation
2 separate RT doses < 1 combined RT dose
-cell repair damage between doses and repopulate
Fractionation reduces self tissue toxicity
Limitations
-GA, cost, compliance (hospitalisation and frequent visits)
RT tumours
Smaller are more sensitive
Most sensitive
-lymphoma, transmissible venereal, acanthomatous ameloblastoma
Mid
-Oral SCC (dog)
-brain
Poor
-fibrosarcoma
-osteosarcoma
-feline oral SCC
Tumour response varies (type and sit)
RT side effects
Acute and late
Tissue in irradiated area will be affected
Damage apparent following division of cells (days rapid, year slow division)
Ac
-skin, MM
-resolve within few weeks
Late
-ischaemic necrosis (bone and brain)
-alopecia
Carcinogenic (years, avoid in young patients)
Chemotherapy use
1°- sole Tx for sensitive tumours
Adjuvant - post Sx for metastic Dz
Neoadjuvant- Tx pre Sx to shrink, easier resection
Concurrent with RT - increase sensitivity to RT
Tumour cell heterogenity
Cancer is the result of genetic instability
Tumours produce subclones with more mutations
Resistant clones can form
Chemo success factors
Tumour cell heterogeneity
Inherent tumour sensitivity
Drug dosage
Tumour supply
Tx interval
Factors affecting chemo response
Administration
Distribution
Metabolism
Excretion
Polychemotherapy
Sequential - several drugs at different times
Combo - several given simultaneously
Avoid topical/ intratumoural
Env. contamination risk
High dose chemo has narrow therapeutic range
Chemo tox
Immediate
-Anaphylaxis, arrhythmia, emesis
Acute tumour lysis syndrome
-large burden/ rapid tumour destruction
Rapidly dividing cells most affected
Bone marrow
Alopecia (uncommon in smallies)
GI
-enterocyte damage, mucosal barrier compromised, maropitant
7-10d post Tx
-Haematopoietic cell damage (low neutrophil count)
-pyrexic/ afebrile neutropenic
Drug associated complications
Doxorubicin - Canine cardiotoxicity
Cyclophosphamide - sterile haemorrhagic cystitis
Lomustine - hepatoxicity
Cisplatin - nephrotoxic
Vincristine - peripheral neuropathy
Extravasation - perivascular irritants - doxorubicin, vincristone
0raise and rawn back vein
Metronomic chemo
Continuous low dose chemo (less dose, more doses)
Palliative/ following MTD chemo
Targets angiogenesis
Stim immune response
Cyclophosphamides w/ piroxicam
TKI
Tyrosine Kinase Inhibitors
Inhibit activation of cancer signalling pathways (specific neos)
-affect angiogenesis, toxicity, need monitoring
Mastinib oral for Mast Cell Tumour
Adv- D+. anorexia, bone marrow suppression
Lymphoma clinical presentations (dogs)
Mid to old aged
CS dependent on tumour sites
Multicentric 80%
Mediastinal and GI 5% each
Canine multicentric lymphoma
Generalised peripheral lymphadenopathy
CS- enlarged LN, D+, V+, anorexia, lethargy
Cranial mediastinal canine lymphoma
Solitary or part of multicentric form
Tachy & dyspnoea
Hyper Ca signs (PUPD, V+, tremors)
Altered cardiac PMI
Canine alimentary lymphoma
CS- V+, D+, pan hypoproteinaemia, abdominal masses
Aggressive form
Cutaneous lymphoma
Epitheliotropic - T cell
Non epitheliotropic - B cell, multi lesions
Raised erythematous plaques
Poor chemo response
Paraneoplastic syndrome
HyperCa
IMHA
Monoclonal gammopathies
Neuropathies
Cachexia